The Enterprise Value as of December 2024 (TTM) for Intellia Therapeutics, Inc. (NTLA) is 1.21B

According to Intellia Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 1.21B. This represents a change of -48.34% compared to the average of 2.35B of the last 4 quarters.

Intellia Therapeutics, Inc. (NTLA) Historical Enterprise Value (quarterly & annually)

How has NTLA Enterprise Value performed in the past?

The mean historical Enterprise Value of Intellia Therapeutics, Inc. over the last ten years is 1.80B. The current 1.21B Enterprise Value has changed 6.64% with respect to the historical average. Over the past ten years (40 quarters), NTLA's Enterprise Value was at its highest in in the June 2021 quarter at 10.98B. The Enterprise Value was at its lowest in in the December 2014 quarter at 54.47M.

Intellia Therapeutics, Inc. (NTLA) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Intellia Therapeutics, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Intellia Therapeutics, Inc. (NTLA) Average Enterprise Value

How has NTLA Enterprise Value performed in the past?

The current Enterprise Value of Intellia Therapeutics, Inc. (NTLA) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Intellia Therapeutics, Inc. (NTLA) Enterprise Value vs. Peers

How is NTLA’s Enterprise Value compared to its peers?

Intellia Therapeutics, Inc.’s Enterprise Value is greater than Editas Medicine, Inc. (45.84M), greater than Caribou Biosciences, Inc. (156.76M), less than CRISPR Therapeutics AG (3.46B), greater than Verve Therapeutics, Inc. (412.06M), less than Beam Therapeutics Inc. (2.31B), greater than Fate Therapeutics, Inc. (250.13M), less than Vertex Pharmaceuticals Incorporated (100.83B), greater than Ginkgo Bioworks Holdings, Inc. (373.13M), greater than Prime Medicine, Inc. (291.83M), greater than Sana Biotechnology, Inc. (333.02M),

Build a custom stock screener for Intellia Therapeutics, Inc. (NTLA) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Intellia Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Intellia Therapeutics, Inc. (NTLA) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Intellia Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.